Ventyx Biosciences Inc (VTYX)
2.31
-0.05
(-2.12%)
USD |
NASDAQ |
Sep 27, 16:00
2.32
+0.01
(+0.43%)
After-Hours: 20:00
Ventyx Biosciences Accounts Payable (Quarterly): 6.583M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.583M |
| March 31, 2024 | 5.583M |
| December 31, 2023 | 5.756M |
| September 30, 2023 | 9.338M |
| June 30, 2023 | 4.085M |
| March 31, 2023 | 6.552M |
| December 31, 2022 | 6.433M |
| Date | Value |
|---|---|
| September 30, 2022 | 18.58M |
| June 30, 2022 | 5.805M |
| March 31, 2022 | 7.114M |
| December 31, 2021 | 4.661M |
| September 30, 2021 | 4.263M |
| June 30, 2021 | 2.373M |
| December 31, 2020 | 1.102M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.102M
Minimum
Dec 2020
18.58M
Maximum
Sep 2022
6.302M
Average
5.780M
Median
Accounts Payable (Quarterly) Benchmarks
| Pfizer Inc | 5.106B |
| Altimmune Inc | 2.688M |
| Viking Therapeutics Inc | 11.09M |
| vTv Therapeutics Inc | -- |
| Structure Therapeutics Inc | 2.209M |